These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28602012)

  • 1. Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer's disease.
    Alexopoulos P; Gleixner LS; Werle L; Buhl F; Thierjung N; Giourou E; Kagerbauer SM; Gourzis P; Kübler H; Grimmer T; Yakushev I; Martin J; Kurz A; Perneczky R
    Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):519-524. PubMed ID: 28602012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of plasma soluble amyloid precursor protein beta in Alzheimer's disease.
    Yun SM; Cho SJ; Jo C; Park MH; Han C; Koh YH
    Arch Gerontol Geriatr; 2020; 87():103995. PubMed ID: 31874328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia.
    Alexopoulos P; Thierjung N; Economou P; Werle L; Buhl F; Kagerbauer S; Papanastasiou AD; Grimmer T; Gourzis P; Berthele A; Hemmer B; Kübler H; Martin J; Politis A; Perneczky R
    J Alzheimers Dis; 2019; 69(1):83-90. PubMed ID: 30909232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High performance plasma amyloid-β biomarkers for Alzheimer's disease.
    Nakamura A; Kaneko N; Villemagne VL; Kato T; Doecke J; Doré V; Fowler C; Li QX; Martins R; Rowe C; Tomita T; Matsuzaki K; Ishii K; Ishii K; Arahata Y; Iwamoto S; Ito K; Tanaka K; Masters CL; Yanagisawa K
    Nature; 2018 Feb; 554(7691):249-254. PubMed ID: 29420472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
    Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
    Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid BACE1 Activity and sAβPPβ as Biomarker Candidates of Alzheimer's Disease.
    Alexopoulos P; Thierjung N; Grimmer T; Ortner M; Economou P; Assimakopoulos K; Gourzis P; Politis A; Perneczky R;
    Dement Geriatr Cogn Disord; 2018; 45(3-4):152-161. PubMed ID: 29788013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and neurobiological correlates of soluble amyloid precursor proteins in the cerebrospinal fluid.
    Alexopoulos P; Tsolakidou A; Roselli F; Arnold A; Grimmer T; Westerteicher C; Leante MR; Förstl H; Livrea P; Kurz A; Perneczky R
    Alzheimers Dement; 2012 Jul; 8(4):304-11. PubMed ID: 22055653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer's disease.
    Perneczky R; Guo LH; Kagerbauer SM; Werle L; Kurz A; Martin J; Alexopoulos P
    Transl Psychiatry; 2013 Feb; 3(2):e227. PubMed ID: 23423136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal platelet amyloid-β protein precursor (AβPP) metabolism in Alzheimer's disease: identification and characterization of a new AβPP isoform as potential biomarker.
    Jelic V; Hagman G; Yamamoto NG; Teranishi Y; Nishimura T; Winblad B; Pavlov PF
    J Alzheimers Dis; 2013; 35(2):285-95. PubMed ID: 23388171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease.
    Pereira Vatanabe I; Peron R; Mantellatto Grigoli M; Pelucchi S; De Cesare G; Magalhães T; Manzine PR; Figueredo Balthazar ML; Di Luca M; Marcello E; Cominetti MR
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
    VanItallie TB
    Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Zainaghi IA; Talib LL; Diniz BS; Gattaz WF; Forlenza OV
    J Neural Transm (Vienna); 2012 Jul; 119(7):815-9. PubMed ID: 22573143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma SUMO1 Protein is Elevated in Alzheimer's Disease.
    Cho SJ; Yun SM; Lee DH; Jo C; Ho Park M; Han C; Ho Koh Y
    J Alzheimers Dis; 2015; 47(3):639-43. PubMed ID: 26401699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease.
    Shi Y; Gu L; Wang Q; Gao L; Zhu J; Lu X; Zhou F; Zhu D; Zhang H; Xie C; Zhang Z
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):664-670. PubMed ID: 31336382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
    Dayon L; Wojcik J; Núñez Galindo A; Corthésy J; Cominetti O; Oikonomidi A; Henry H; Migliavacca E; Bowman GL; Popp J
    J Alzheimers Dis; 2017; 60(4):1641-1652. PubMed ID: 29125490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-β as a Blood Biomarker for Alzheimer's Disease: A Review of Recent Literature.
    Wang X; Sun Y; Li T; Cai Y; Han Y
    J Alzheimers Dis; 2020; 73(3):819-832. PubMed ID: 31868667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
    Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
    Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.